Docstoc

Idenix Pharmaceuticals

Document Sample
Idenix Pharmaceuticals Powered By Docstoc
					Idenix Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011

Summary

Companys pharmaceuticals report, “Idenix Pharmaceuticals, Inc. – Product Pipeline Review –
H2 2011” provides data on the Idenix Pharmaceuticals, Inc.s research and development focus.
The report includes information on current developmental pipeline, complete with latest updates,
and features on discontinued and dormant projects.

This report is built using data and information sourced from Companys proprietary databases,
Idenix Pharmaceuticals, Inc.s corporate website, SEC filings, investor presentations and featured
press releases, both from Idenix Pharmaceuticals, Inc. and industry–specific third party sources,
put together by Companys team.

Scope

- Idenix Pharmaceuticals, Inc. - Brief Idenix Pharmaceuticals, Inc. overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Idenix Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the
combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Idenix Pharmaceuticals, Inc. with
complete description of the products developmental history, mechanism of action, therapeutic
class, target and major milestones.
- Recent updates of the Idenix Pharmaceuticals, Inc.s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Idenix Pharmaceuticals, Inc.s strategic position with total access to detailed
information on its product pipeline.
- Assess the growth potential of Idenix Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Idenix Pharmaceuticals, Inc.s R&D
portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Idenix Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Idenix Pharmaceuticals, Inc. and identify
potential opportunities in those areas.

For more information, please visit :-

Marketing Team
Aarkstore Enterprise
Phone:08149852585
Email:enquiry@aarkstore.com
URL:www.aarkstore.com
http://twitter.com/aarkstoredotcom
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstoreenterprise

http://www.aarkstore.com/reports/Idenix-Pharmaceuticals-Inc-Product-Pipeline-Review-H2-
2011-155547.html

More Related Reports :-

Idenix Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011
Kowa Company, Ltd. – Product Pipeline Review – H2 2011
Nycomed International Management GmbH – Product Pipeline Review – H2 2011
AKELA Pharma Inc. – Product Pipeline Review – H2 2011
Ardea Biosciences, Inc. – Product Pipeline Review – H2 2011
Genmab A/S – Product Pipeline Review – H2 2011
ARQULE, INC – Product Pipeline Review – H2 2011
Zalicus Inc. – Product Pipeline Review – H2 2011
Ark Therapeutics Group plc – Product Pipeline Review – H2 2011
Idera Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:4
posted:11/28/2011
language:English
pages:2